Last update:

Oncology & Cancer news

Oncology & Cancer

Breast, cervical, CRC screening below Healthy People 2020 targets

Receipt of screening tests for breast, cervical, and colorectal cancers was below national Heathy People 2020 targets in 2018, according to research published in the Jan. 14 issue of the U.S. Centers for Disease Control and ...

Oncology & Cancer

Living macrophage-based drug promotes antitumor immunotherapy

Immunotherapy is one of the most promising approaches to inhibit tumor growth and metastasis by activating host immune functions. However, so far, immunotherapy still exhibits limitations of efficacy and safety, such as huge ...

Oncology & Cancer

New computational method detects disrupted pathways in cancer

Cancer is a notoriously complex disease, in part because it may be caused by mutations among hundreds or even thousands of genes. In addition, most cancers exhibit an extraordinary amount of variation among genetic mutations, ...

Oncology & Cancer

The backlog in mammograms during the COVID-19 pandemic

At its onset, the COVID-19 pandemic severely disrupted medical care, as millions of elective procedures were postponed or canceled. While the volume of many procedures rebounded by the end of July 2020, the disruption caused ...

Oncology & Cancer

Scientists develop approach for exploiting cancer's dietary demands

Numerous studies in mice and cancer cells have shown cancer growth can be reduced in response to diets lacking serine. But results have been variable because some cancer cells are efficient in making their own serine, particularly ...

Medical research

A new strategy for making blood stem cells healthier

The hematopoietic (blood-forming) stem cells (HSCs) residing in our bone marrow produce all of our blood cells, including key immune cells that protect us from bacteria and viruses. As we age, our HSCs become less efficient ...

Oncology & Cancer

The role of T cells in fighting cancer

New research from CU Cancer Center member Jing Hong Wang, MD, Ph.D., and recent University of Colorado Immunology program graduate Rachel Woolaver, Ph.D., may help researchers develop more effective personalized immunotherapy ...

Oncology & Cancer

Bladder cancer—when to use chemotherapy

In patients with bladder cancer, chemotherapy effectiveness is partially determined by the body's immune system response to the malignancy. This is the conclusion of research conducted by a team of scientists from Charité ...

Oncology & Cancer

Killing cancer by unleashing the body's own immune system

The body's immune system is the first line of defense against infections like bacteria, viruses or cancers. Some cancers, however, have developed the art of molecular deception to avoid destruction by the body's immune system. ...

Oncology & Cancer

Research explores how melanoma grows and spreads

The first step in treating cancer is understanding how it starts, grows and spreads throughout the body. A relatively new cancer research approach is the study of metabolites, the products of different steps in cancer cell ...

Oncology & Cancer

Big data analysis finds cancer's key vulnerabilities

Thousands of different genetic mutations have been implicated in cancer, but a new analysis of almost 10,000 patients found that regardless of the cancer's origin, tumors could be stratified in only 112 subtypes and that, ...

Oncology & Cancer

Ultraviolet radiation causes rare type of eye cancer

Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma, according to research funded by Cancer Research UK and others and published in Nature Communications today.

Oncology & Cancer

A new, potent weapon against lymphomas

MDC researchers have developed a new approach to CAR T-cell therapy. The team has shown in Nature Communications that the procedure is very effective, especially when it comes to fighting follicular lymphomas and chronic ...